14.97
price down icon3.04%   -0.47
after-market Handel nachbörslich: 14.97
loading
Schlusskurs vom Vortag:
$15.44
Offen:
$15.45
24-Stunden-Volumen:
89,619
Relative Volume:
0.42
Marktkapitalisierung:
$560.64M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
-1.96%
1M Leistung:
+4.69%
6M Leistung:
+47.63%
1J Leistung:
-46.52%
1-Tages-Spanne:
Value
$14.70
$15.45
1-Wochen-Bereich:
Value
$14.61
$16.12
52-Wochen-Spanne:
Value
$5.485
$31.13

Oruka Therapeutics Inc Stock (ORKA) Company Profile

Name
Firmenname
Oruka Therapeutics Inc
Name
Telefon
650-606-7910
Name
Adresse
855 OAK GROVE AVE., MENLO PARK
Name
Mitarbeiter
28
Name
Twitter
Name
Nächster Verdiensttermin
2024-11-04
Name
Neueste SEC-Einreichungen
Name
ORKA's Discussions on Twitter

Vergleichen Sie ORKA mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
ORKA
Oruka Therapeutics Inc
14.97 582.73M 0 0 0 0.00
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
396.93 102.81B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
453.54 58.59B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
567.22 61.25B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ARGX
Argen X Se Adr
733.66 43.23B 3.06B 1.28B 447.35M 21.30
Biotechnology icon
ONC
Beone Medicines Ltd Adr
318.73 36.53B 3.81B -644.79M -669.77M -6.24

Oruka Therapeutics Inc Stock (ORKA) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-05-22 Eingeleitet BTIG Research Buy
2025-02-04 Eingeleitet Wolfe Research Outperform
2024-10-11 Eingeleitet Stifel Buy
2024-10-07 Eingeleitet H.C. Wainwright Buy
2024-09-17 Eingeleitet Leerink Partners Outperform
2024-09-16 Eingeleitet TD Cowen Buy
2024-09-13 Eingeleitet Jefferies Buy
2018-02-27 Eingeleitet Ascendiant Capital Markets Buy
2013-10-09 Eingeleitet Dawson James Buy
Alle ansehen

Oruka Therapeutics Inc Aktie (ORKA) Neueste Nachrichten

pulisher
Sep 04, 2025

Will Oruka Therapeutics Inc. outperform the market2025 Year in Review & Real-Time Stock Price Movement Reports - Newser

Sep 04, 2025
pulisher
Sep 04, 2025

Forecast Cut: What are Oruka Therapeutics Inc.’s technical support levelsInsider Selling & Real-Time Buy Signal Alerts - khodrobank.com

Sep 04, 2025
pulisher
Sep 04, 2025

Oruka Therapeutics Inc. stock trendline breakdown2025 Price Action Summary & Free Long-Term Investment Growth Plans - Newser

Sep 04, 2025
pulisher
Sep 04, 2025

Rate Hike: Will Oruka Therapeutics Inc. face regulatory challengesJuly 2025 Review & Low Risk High Reward Trade Ideas - khodrobank.com

Sep 04, 2025
pulisher
Sep 04, 2025

Aug Intraday: Will Oruka Therapeutics Inc. face regulatory challengesQuarterly Market Review & Expert Approved Momentum Ideas - khodrobank.com

Sep 04, 2025
pulisher
Sep 04, 2025

Will Oruka Therapeutics Inc. stock hit new highs in YEARPortfolio Update Report & Weekly Watchlist of Top Performers - khodrobank.com

Sep 04, 2025
pulisher
Sep 04, 2025

Does Oruka Therapeutics Inc. fit your quant trading modelJuly 2025 News Drivers & Daily Technical Forecast Reports - Newser

Sep 04, 2025
pulisher
Sep 03, 2025

Market Review: Can Oruka Therapeutics Inc. expand into new marketsGap Up & Low Risk High Reward Ideas - khodrobank.com

Sep 03, 2025
pulisher
Sep 03, 2025

Will a bounce in Oruka Therapeutics Inc. offer an exitWeekly Profit Summary & Daily Volume Surge Trade Alerts - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Using data filters to optimize entry into Oruka Therapeutics Inc.Weekly Trend Summary & Technical Entry and Exit Alerts - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Short interest data insights for Oruka Therapeutics Inc.Portfolio Risk Summary & Real-Time Market Trend Scan - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Sector ETF performance correlation with Oruka Therapeutics Inc.July 2025 Closing Moves & Weekly Chart Analysis and Guides - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Revenue Check: Can Oruka Therapeutics Inc. expand into new marketsMarket Rally & Stepwise Entry and Exit Trade Signals - khodrobank.com

Sep 03, 2025
pulisher
Sep 03, 2025

How to read the order book for Oruka Therapeutics Inc.Index Update & Low Drawdown Trading Techniques - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Is Oruka Therapeutics Inc. stock trending bullishFed Meeting & Free Long-Term Investment Growth Plans - khodrobank.com

Sep 03, 2025
pulisher
Sep 03, 2025

How to monitor Oruka Therapeutics Inc. with trend dashboardsJuly 2025 Earnings & Reliable Momentum Entry Alerts - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Oruka Therapeutics, Inc. (NASDAQ:ORKA) Given Consensus Recommendation of “Buy” by Brokerages - Defense World

Sep 03, 2025
pulisher
Sep 03, 2025

Oruka Therapeutics Inc. stock chart pattern explainedMarket Performance Recap & Fast Exit and Entry Strategy Plans - Newser

Sep 03, 2025
pulisher
Sep 02, 2025

Is this a good reentry point in Oruka Therapeutics Inc.Earnings Growth Summary & Real-Time Chart Breakout Alerts - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

Oruka Therapeutics Inc. recovery potential after sell offLayoff News & Risk Controlled Stock Pick Alerts - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

How high can Oruka Therapeutics Inc. stock goBond Market & Long Hold Capital Preservation Tips - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

Analyzing recovery setups for Oruka Therapeutics Inc. investorsInsider Buying & Reliable Breakout Forecasts - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

Is Oruka Therapeutics Inc. still worth holding after the dipEarnings Risk Summary & High Accuracy Trade Signal Alerts - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

Is Oruka Therapeutics Inc. stock a good pick for beginners2025 Market WrapUp & Weekly Top Gainers Trade List - khodrobank.com

Sep 02, 2025
pulisher
Sep 02, 2025

Is Oruka Therapeutics Inc. part of any ETFJuly 2025 Action & High Accuracy Buy Signal Tips - khodrobank.com

Sep 02, 2025
pulisher
Sep 01, 2025

What MACD signals say about Oruka Therapeutics Inc.July 2025 Gainers & Weekly High Conviction Trade Ideas - Newser

Sep 01, 2025
pulisher
Sep 01, 2025

Is Oruka Therapeutics Inc. undervalued by DCF analysis2025 Dividend Review & Real-Time Chart Breakout Alerts - khodrobank.com

Sep 01, 2025
pulisher
Sep 01, 2025

What are the future prospects of Oruka Therapeutics Inc.Weekly Earnings Recap & Capital Efficiency Focused Strategies - khodrobank.com

Sep 01, 2025
pulisher
Sep 01, 2025

Does Oruka Therapeutics Inc. qualify in momentum factor screeningJuly 2025 Outlook & Stepwise Trade Signal Implementation - Newser

Sep 01, 2025
pulisher
Sep 01, 2025

What data driven models say about Oruka Therapeutics Inc.’s futureTrend Reversal & Capital Protection Trade Alerts - Newser

Sep 01, 2025
pulisher
Aug 31, 2025

How Oruka Therapeutics Inc. stock performs during market volatilityEarnings Beat & AI Forecasted Stock Moves - 선데이타임즈

Aug 31, 2025
pulisher
Aug 31, 2025

Evaluating Oruka Therapeutics Inc. with trendline analysisJuly 2025 EndofMonth & AI Powered Trade Plan Recommendations - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

What’s the profit margin of Oruka Therapeutics Inc.July 2025 Update & Free Risk Controlled Daily Trade Plans - 선데이타임즈

Aug 31, 2025
pulisher
Aug 31, 2025

Applying Elliott Wave Theory to Oruka Therapeutics Inc.2025 Market Outlook & Reliable Breakout Forecasts - Newser

Aug 31, 2025
pulisher
Aug 30, 2025

Oruka Therapeutics Inc.’s volatility index tracking explainedWeekly Profit Summary & Daily Chart Pattern Signals - Newser

Aug 30, 2025

Finanzdaten der Oruka Therapeutics Inc-Aktie (ORKA)

Es liegen keine Finanzdaten für Oruka Therapeutics Inc (ORKA) vor. Überprüfen Sie andere Aktien für weitere Informationen.

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Oruka Therapeutics Inc-Aktie (ORKA) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
Venrock Healthcare Capital Par
10% Owner
Feb 13 '25
Buy
11.63
14,950
173,868
4,059,634
Venrock Healthcare Capital Par
10% Owner
Feb 12 '25
Buy
11.86
8,971
106,396
4,044,684
Venrock Healthcare Capital Par
10% Owner
Feb 11 '25
Buy
10.95
9,593
105,043
4,035,713
Venrock Healthcare Capital Par
10% Owner
Feb 10 '25
Buy
10.90
574
6,257
4,026,120
$85.44
price down icon 1.75%
$27.38
price up icon 1.11%
$23.80
price up icon 1.19%
$103.50
price up icon 3.07%
$142.53
price down icon 0.68%
biotechnology ONC
$318.73
price down icon 5.21%
Kapitalisierung:     |  Volumen (24h):